FDA Approved: DULOXETINE — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved a supplemental application for duloxetine from Zydus Lifesciences Limited under an ANDA. The approval involves changes to the approved product (suc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathic Pain
• Fibromyalgia
• Generalized Anxiety Disorder
• Major Depressive Disorder
• Musculoskeletal Pain

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

SUPPL AP for DULOXETINE (DULOXETINE)